Literature DB >> 16517256

What went wrong in the natalizumab trials?

Annette Langer-Gould1, Lawrence Steinman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517256     DOI: 10.1016/S0140-6736(06)68279-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  [Clinical drug therapy].

Authors:  Markus Müller
Journal:  Wien Med Wochenschr       Date:  2006-09

2.  Biological therapies: concepts and challenges.

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

3.  Stem cells and a cure for type 1 diabetes?

Authors:  John A Todd
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-09       Impact factor: 11.205

Review 4.  New developments in understanding and treating neuroinflammation.

Authors:  C Infante-Duarte; S Waiczies; J Wuerfel; F Zipp
Journal:  J Mol Med (Berl)       Date:  2008-01-15       Impact factor: 4.599

5.  Immune response to controlled release of immunomodulating peptides in a murine experimental autoimmune encephalomyelitis (EAE) model.

Authors:  Hong Zhao; Paul Kiptoo; Todd D Williams; Teruna J Siahaan; Elizabeth M Topp
Journal:  J Control Release       Date:  2009-09-12       Impact factor: 9.776

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.